Asset Manager

Updated:

Upperline Health

Upperline Health: Will W. Savage, CEO. Provider of value-based lower-extremity care across seven states, backed by General Atlantic and Frist Cressey.

Upperline Health

Upperline Health was founded in 2017 by CEO Will W. Savage and Dr. Andrew Woods, who serves as Chief Medical Officer. The company raised capital from private-equity backers including General Atlantic, which led a $58M series B round in 2021, and Frist Cressey Ventures, the healthcare-focused venture firm co-founded by former Senate Majority Leader Bill Frist. The venture's model consolidates independent podiatry and vascular practices into a single network, adding ancillary services such as wound care centers and diagnostic imaging. The firm targets two principal asset classes: value-based risk contracts with Medicare and commercial payers, and ownership of ambulatory surgery centers. Upperline operates in at least seven states—Tennessee, Texas, Florida, Georgia, Alabama, Mississippi, and Louisiana—with a stated focus on underserved rural and suburban markets. As of 2023, the network included more than 150 providers across 80-plus clinic locations, supported by centralized billing, quality reporting, and patient outreach systems. The clinical focus is chronic conditions of the lower extremity: diabetic foot ulcers, peripheral artery disease, venous insufficiency, and Charcot foot. Upperline Health employs a hub-and-spoke model: regional care hubs anchor outpatient surgery and advanced wound care, while spoke clinics provide routine podiatry and screening. Operating companies include Nashville-based physicians group Premier Podiatry and surgical centers in Dallas and Houston. In 2024, the firm announced it had treated over 100,000 unique patients, with more than half covered under a value-based arrangement that ties reimbursement to clinical outcomes and cost reduction rather than volume. Adjacent ventures include a physician-liability captive and a clinical research arm that publishes outcomes in peer-reviewed journals. The structural differentiator is a risk-bearing clinic platform focused entirely on lower-extremity care, one of the highest-cost categories for Medicare, Medicaid, and managed-care plans. Unlike general primary-care aggregators, Upperline captures both physician fees and facility fees while controlling the full episode of care—from screening through surgery and wound monitoring. Its governance includes a board of physician partners and representatives from General Atlantic, Frist Cressey, and Health Velocity Capital.

General information

Firm type

Asset Manager

Year founded

2017

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Nashville

Corporate office

Nashville, TN, United States

Principals

Will W. Savage

Chief Executive Officer

Dr. Andrew Woods

Chief Medical Officer

Sector focus

Healthcare Services

Frequently asked questions

Who runs investment decisions at Upperline Health?

CEO Will W. Savage sets strategy, while clinical direction is led by Dr. Andrew Woods as Chief Medical Officer. The board includes representatives from private-equity investors General Atlantic, Frist Cressey Ventures, and Health Velocity Capital, who participate in capital allocation decisions.

How does Upperline Health source proprietary deal flow?

The firm identifies independent podiatry, vascular surgery, and wound care practices seeking to transition to value-based care. It partners with physicians through practice acquisitions and joint ventures, using its centralized infrastructure to improve margins and outcomes while maintaining local brand identity.

Is Upperline Health structured as a single family office or does it operate more like a venture firm?

Neither—Upperline is a healthcare operating company backed by institutional capital including General Atlantic, Frist Cressey Ventures, and Health Velocity Capital. It functions as a management services organization and physician practice aggregator, not a family office or venture fund.

What investment stages does Upperline Health typically target?

Upperline makes growth-stage investments in existing physician practices (typically $1M–$10M per transaction) and greenfield ambulatory surgery centers. It does not seed startups but rather acquires established, revenue-generating clinics with ≥3 providers and ≥5 years of operating history.

Which sectors does Upperline Health explicitly avoid?

Upperline has no disclosed avoidance list, but all of its disclosed activities focus on lower-extremity care. It does not operate in primary care, pediatrics, or general surgery beyond the foot and ankle.

How is Upperline Health related to General Atlantic?

General Atlantic led Upperline's $58M series B round in 2021 and holds a board seat. The private-equity firm typically retains minority stakes in growth healthcare platforms; it has invested across multiple provider aggregators including more than a dozen physician-practice roll-ups.

Where does the underlying wealth come from?

Upperline Health is not a family office—its capital comes from institutional investors: pension funds, endowments, and high-net-worth individuals that invest in General Atlantic, Frist Cressey Ventures, and Health Velocity Capital funds.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo